Print
Health Care

New Lab In Wisconsin Expands Wilmington Based PPD's Testing Capabilities

By Jenny Callison, posted Mar 29, 2018
PPD this week announced a new analytical laboratory at its existing facility in Middleton, Wisconsin. The lab will expand PPD’s testing capacity, according to an announcement Wednesday by the Wilmington-based company.

The 32,000-square-foot Good Manufacturing Practices (GMP) lab “supplements the company’s existing biologics capacity and was constructed specifically for the stability and quality control testing of large molecule drug products,” the news release stated.

Planned for a workforce of more than 100, the new lab contains specialized areas designed for particular types of assays and scientific instrumentation specific to biologics, according to the release.

Biological products, or biologics, include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues and recombinant therapeutic proteins.

According to the Federal Drug Administration, biologics – as distinguished from chemical synthetics – are products isolated from a variety of natural sources. 

“The expansion of our biologics testing, which nearly doubles our analytical testing capacity, enables us to meet the ever-growing needs of our clients for GMP testing of large molecule products,” Jon Denissen, senior vice president of the PPD Laboratories bioanalytical and GMP labs, said in the release. “From early clinical development through commercial release testing, clients rely on our industry-leading capabilities in large molecule product testing. With deep expertise that spans the full spectrum of protein-based and gene-based biologics, we support many of the most cutting-edge immuno-oncology, gene therapy and cell therapy agents being developed or marketed today.”

PPD is also renovating its existing cell lab at the Middleton campus to double the lab’s capacity for GMP cell-based assays, the release stated, adding, “The expanded 5,900-square-foot laboratory will support a total of 70 cellular and molecular biology scientists upon its completion in mid-2018.”
Ico insights

INSIGHTS

SPONSORS' CONTENT
Mike stonestreet 300x300

Best Practices For Virtual Board Meetings

Mike Stonestreet - CAMS (Community Association Management Services)
Chris coudriet

New Hanover County Offers Expertise And Resources For Safe Reopening

Chris Coudriet - New Hanover County Government
Aaeaaqaaaaaaaaidaaaajdhiztrkodm0lte2yjetngrkmy1hotrmltawmdvlmwqyztmymw

Strategy 101 For Startups

Diane Durance - UNCW Center for Innovation and Entrepreneurship

Trending News

California-based Tech Company Opens An Office In Wilmington

Johanna Cano - Jun 4, 2020

Joint Venture Buys Private Marine Terminal In Wilmington

Christina Haley O'Neal - Jun 4, 2020

Colleagues Remember Pat Leonard As Student Advocate, Strong Voice For Inclusion

Jenny Callison - Jun 4, 2020

Live Oak Investment Subsidiary Grows Through Acquisition

Jenny Callison - Jun 5, 2020

Alcami Announces New CEO

Cece Nunn - Jun 4, 2020

In The Current Issue

N.C. Ports Sets Sail With Big Opportunities

The MV Hyundai Hope’s trip to the port May 20 marked a significant step in developing economic oppor­tunities for the region and state, said...


Addressing Chronic Illnesses Online

Chronic diseases continue to be a focus for the YMCA of Southeastern North Caroli­na, which recently re­structured its evidence-based health...


Goudarzi Reopens Scarless Vein Care In Leland In May

Surgeon Kamran Goudarzi is relaunching his Scarless Vein Care as an independent boutique practice. Click for more....

Book On Business

The 2020 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

2020 Leadership Accelerator: Virtual Workshops for Real Leaders
2019 Health Care Heroes
August 26, 2019 Power Breakfast: A Healthy Sale?
2019 WilmingtonBiz Expo Keynote Lunch - CEO, nCino, Pierre Naude`